Start4DX • ASX
add
4DMedical Ltd
Seneste lukkekurs
0,56 $
Dagsinterval
0,59 $ - 0,63 $
Årsinterval
0,41 $ - 0,83 $
Markedsværdi
250,69 mio. AUD
Gns. volumen
904,84 t
P/E-værdi
-
Udbytteprocent
-
Primær børs
ASX
Markedsnyheder
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
(AUD) | jun. 2024info | År til år-ændring |
---|---|---|
Indtægt | 1,48 mio. | 1.172,70 % |
Driftsudgifter | 12,56 mio. | 11,42 % |
Nettoindtægt | -10,19 mio. | -33,78 % |
Overskudsgrad | -687,84 | 89,49 % |
Earnings per share | — | — |
EBITDA | -11,09 mio. | -5,51 % |
Effektiv afgiftssats | -0,01 % | — |
Årsbalance
Samlede aktiver
Samlede passiver
(AUD) | jun. 2024info | År til år-ændring |
---|---|---|
Kontanter og korttidsinvesteringer | 30,61 mio. | -56,01 % |
Samlede aktiver | 120,02 mio. | 29,16 % |
Samlede passiver | 49,09 mio. | 128,71 % |
Samlet egenkapital | 70,93 mio. | — |
Shares outstanding | 410,53 mio. | — |
Kurs/indre værdi | 3,32 | — |
Afkast af aktiver | -23,28 % | — |
Afkast af kapital | -36,73 % | — |
Pengestrøm
Nettoændring i likviditet
(AUD) | jun. 2024info | År til år-ændring |
---|---|---|
Nettoindtægt | -10,19 mio. | -33,78 % |
Pengestrøm fra drift | -8,06 mio. | 8,54 % |
Pengestrøm fra investering | -339,48 t | -21,29 % |
Pengestrøm fra finansiering | -233,98 t | -101,11 % |
Nettoændring i likviditet | -8,64 mio. | -172,48 % |
Fri pengestrøm | -5,43 mio. | 13,25 % |
Om
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Administrerende direktør
Grundlagt
2013
Website
Ansatte
145